32 84

Cited 0 times in

An open-label, multicenter, phase II single arm trial of osimertinib in non-small cell lung cancer patients with uncommon EGFR mutation (KCSG-LU15-09)

Authors
Ahn, MJ; Cho, JH; Sun, JM; Lee, SH; Ahn, JS; Park, K; Park, KU; Kang, EJ; Choi, YH; Kim, KH; An, HJ; Lee, HW
Citation
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 36(15S):9050-9050, 2018
Journal Title
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
ISSN
0732-183X1527-7755
DOI
10.1200/JCO.2018.36.15_suppl.9050
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Hematology-Oncology
AJOU Authors
이, 현우
Files in This Item:
10.1200_JCO.2018.36.15_suppl.9050.pdfDownload
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse